-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Downgrades Chemours to Neutral, Lowers Price Target to $15

Benzinga·10/14/2026 09:46:26
Listen to the news
Mizuho analyst John Roberts downgrades Chemours (NYSE:CC) from Outperform to Neutral and lowers the price target from $18 to $15.